MedPath

Sumatriptan non-responders: evaluation of a possible biomarker.

Recruiting
Conditions
Migraine
Registration Number
NL-OMON27172
Lead Sponsor
Erasmus MC
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
21
Inclusion Criteria

• Age between 18 and 50 years

• Male or female

Exclusion Criteria

• History of cardiovascular disease

• Perimenopausal status of females

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of change in dermal blood flow response to capsaicin application and saline iontophoresis after sumatriptan or placebo administration.
Secondary Outcome Measures
NameTimeMethod
• Heat sensation after capsaicin application<br /><br>• Blood pressure changes after sumatriptan use
© Copyright 2025. All Rights Reserved by MedPath